Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981524043> ?p ?o ?g. }
- W2981524043 endingPage "1327" @default.
- W2981524043 startingPage "1311" @default.
- W2981524043 abstract "The dipeptidyl peptidase-4 inhibitor (DPP-4i) alogliptin is an oral, antidiabetic treatment that is approved in many countries to treat patients with type 2 diabetes mellitus (T2DM), including the USA, Europe, and Japan. Alogliptin is efficacious both as monotherapy and as add-on/combination therapy with other commonly prescribed T2DM treatments, such as metformin and pioglitazone. Overall, alogliptin is well-tolerated in patients with T2DM, including older patients, those with renal and/or hepatic impairment, and those at high risk of cardiovascular events. There is a low risk of hypoglycemia, weight gain, acute pancreatitis, and gastrointestinal adverse events with alogliptin treatment, as demonstrated in long-term trials (lasting up to 4.5 years) and in a real-world setting. Additionally, alogliptin has a generally favorable or similar safety profile in comparison to other antidiabetic agents (metformin, thiazolidinediones, sulfonylureas, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors, α-glucosidase inhibitors, and insulin). However, further evaluation would be required to determine the mechanism and effect of alogliptin on heart failure, bullous pemphigoid, and inflammatory bowel disease. Of note, due to the ethnic diversity in the epidemiology of T2DM, alogliptin has been shown to be more efficacious in Asian patients than in non-Asian patients with T2DM, but with a similar tolerability profile. These data indicate that DPP-4is, including alogliptin, are important treatment options, especially for Asian patients with T2DM, for whom they have potential as a first-line therapy. This benefit-risk assessment aims to place alogliptin within the current armamentarium of T2DM and aid physicians when choosing optimal diabetes treatment for their patients." @default.
- W2981524043 created "2019-11-01" @default.
- W2981524043 creator A5021167643 @default.
- W2981524043 creator A5036190568 @default.
- W2981524043 creator A5044528157 @default.
- W2981524043 creator A5059017206 @default.
- W2981524043 date "2019-10-25" @default.
- W2981524043 modified "2023-10-09" @default.
- W2981524043 title "Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus" @default.
- W2981524043 cites W1567871412 @default.
- W2981524043 cites W1569365382 @default.
- W2981524043 cites W1681939708 @default.
- W2981524043 cites W1925960178 @default.
- W2981524043 cites W1964423574 @default.
- W2981524043 cites W1968736342 @default.
- W2981524043 cites W1976026431 @default.
- W2981524043 cites W1981478931 @default.
- W2981524043 cites W1981943536 @default.
- W2981524043 cites W1995201952 @default.
- W2981524043 cites W1997885754 @default.
- W2981524043 cites W1998401806 @default.
- W2981524043 cites W1998735190 @default.
- W2981524043 cites W2009830637 @default.
- W2981524043 cites W2010534563 @default.
- W2981524043 cites W2016298811 @default.
- W2981524043 cites W2016691199 @default.
- W2981524043 cites W2020827332 @default.
- W2981524043 cites W2022921728 @default.
- W2981524043 cites W2027788348 @default.
- W2981524043 cites W2039963918 @default.
- W2981524043 cites W2041080869 @default.
- W2981524043 cites W2042176582 @default.
- W2981524043 cites W2045505493 @default.
- W2981524043 cites W2053939314 @default.
- W2981524043 cites W2058407858 @default.
- W2981524043 cites W2059245135 @default.
- W2981524043 cites W2059897529 @default.
- W2981524043 cites W2061865937 @default.
- W2981524043 cites W2064780710 @default.
- W2981524043 cites W2066734164 @default.
- W2981524043 cites W2067663978 @default.
- W2981524043 cites W2068191705 @default.
- W2981524043 cites W2070153213 @default.
- W2981524043 cites W2074881344 @default.
- W2981524043 cites W2077809624 @default.
- W2981524043 cites W2084403835 @default.
- W2981524043 cites W2086842286 @default.
- W2981524043 cites W2092918268 @default.
- W2981524043 cites W2099475256 @default.
- W2981524043 cites W2100442612 @default.
- W2981524043 cites W2101430875 @default.
- W2981524043 cites W2103487864 @default.
- W2981524043 cites W2104053168 @default.
- W2981524043 cites W2104288577 @default.
- W2981524043 cites W2106154942 @default.
- W2981524043 cites W2107455258 @default.
- W2981524043 cites W2113297547 @default.
- W2981524043 cites W2118701488 @default.
- W2981524043 cites W2123629330 @default.
- W2981524043 cites W2123690908 @default.
- W2981524043 cites W2126946832 @default.
- W2981524043 cites W2127854619 @default.
- W2981524043 cites W2140986962 @default.
- W2981524043 cites W2141164223 @default.
- W2981524043 cites W2141946042 @default.
- W2981524043 cites W2144325462 @default.
- W2981524043 cites W2151668968 @default.
- W2981524043 cites W2157373537 @default.
- W2981524043 cites W2157558120 @default.
- W2981524043 cites W2160088494 @default.
- W2981524043 cites W2160461278 @default.
- W2981524043 cites W2164535707 @default.
- W2981524043 cites W2166623757 @default.
- W2981524043 cites W2167609344 @default.
- W2981524043 cites W2167777458 @default.
- W2981524043 cites W2176525090 @default.
- W2981524043 cites W2182241779 @default.
- W2981524043 cites W2218085405 @default.
- W2981524043 cites W2222692848 @default.
- W2981524043 cites W2225535009 @default.
- W2981524043 cites W2277579395 @default.
- W2981524043 cites W2282623102 @default.
- W2981524043 cites W2287701877 @default.
- W2981524043 cites W2308657818 @default.
- W2981524043 cites W2333003991 @default.
- W2981524043 cites W2338042410 @default.
- W2981524043 cites W2344658675 @default.
- W2981524043 cites W2346951828 @default.
- W2981524043 cites W2353007761 @default.
- W2981524043 cites W2395548559 @default.
- W2981524043 cites W2400829085 @default.
- W2981524043 cites W2417331731 @default.
- W2981524043 cites W2485875310 @default.
- W2981524043 cites W2503545706 @default.
- W2981524043 cites W2517384200 @default.
- W2981524043 cites W2531816236 @default.
- W2981524043 cites W2532555978 @default.
- W2981524043 cites W2544388418 @default.